Differential Cardiometabolic Effects of GLP-1 Receptor Agonists Versus SGLT2 Inhibitors in Early-Onset Type 2 Diabetes: A Randomized Controlled Trial. LMJHCR [Internet]. 2026 Jun. 30 [cited 2026 Jul. 7];4(1):1-9. Available from: https://linkmjhcr.com/index.php/lmj/article/view/189